Analyst Price Targets — ELAN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 6, 2026 10:45 am | — | KeyBanc | $30.00 | $26.22 | TheFly | Elanco price target raised to $30 from $29 at KeyBanc |
| July 22, 2026 12:20 pm | Erin Wright | Morgan Stanley | $26.00 | $25.70 | TheFly | Elanco price target raised to $26 from $23 at Morgan Stanley |
| May 15, 2026 12:27 pm | — | Morgan Stanley | $23.00 | $20.92 | TheFly | Elanco price target lowered to $23 from $24 at Morgan Stanley |
| February 25, 2026 1:33 pm | Steve Dechert | KeyBanc | $29.00 | $27.13 | StreetInsider | 'Elanco Animal Health (ELAN) set up well for beats and raises'; PT Raised to $29 at KeyBanc |
| February 24, 2026 7:50 pm | Daniel Clark | Leerink Partners | $30.00 | $26.37 | TheFly | Elanco price target raised to $30 from $26 at Leerink |
| January 29, 2026 2:33 pm | — | UBS | $30.00 | $24.17 | TheFly | Elanco price target raised to $30 from $27 at UBS |
| January 22, 2026 8:42 am | David Westenberg | Piper Sandler | $30.00 | $24.30 | StreetInsider | Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight |
| December 18, 2025 12:55 pm | — | Morgan Stanley | $22.00 | $22.08 | TheFly | Elanco price target raised to $22 from $18 at Morgan Stanley |
| December 8, 2025 9:26 pm | — | Barclays | $30.00 | $21.69 | TheFly | Elanco initiated with an Overweight at Barclays |
| November 20, 2025 9:21 pm | — | KeyBanc | $27.00 | $21.46 | TheFly | Elanco initiated with an Overweight at KeyBanc |
Latest News for ELAN
Canada Pension Plan Investment Board purchased a new position in Elanco Animal Health Incorporated (NYSE: ELAN) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 51,700 shares of the company's stock, valued at approximately $1,272,000. Several other hedge funds and other institutional investors also
Corient Private Wealth LP purchased a new stake in shares of Elanco Animal Health Incorporated (NYSE: ELAN) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 348,043 shares of the company's stock, valued at approximately $8,565,000. Corient Private Wealth LP owned approximately
Corient Private Wealth LP raised its stake in Elanco Animal Health Incorporated (NYSE: ELAN) by 127.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 348,043 shares of the company's stock after acquiring an additional 195,312 shares during the
Algert Global LLC trimmed its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 19.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 180,430 shares of the company's stock after selling 42,410 shares during the quarter. Algert Global LLC's holdings
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.